iPSC-based drug discovery identified the Hippo signaling pathway as a therapeutic target in the fibrosis of NPHP1-deficient nephronophthisis

Authors

Institutions

Publication Details

Journal
Stem Cell Research & Therapy
Published
2025-09-18
DOI
https://doi.org/10.1186/s13287-025-04567-0
Citations
1
Primary Topic
Renal and related cancers
Type
article
Field-Weighted Citation Impact
0.81

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

iPSC-based drug discovery identified the Hippo signaling pathway as a therapeutic target in the fibrosis of NPHP1-deficient nephronophthisis

Eisei Sohara, Takayasu Mori, Takefumi Suzuki, Tamami Fujiki et al.
1 citations
Stem Cell Research & Therapy
Renal and related cancers
0.81
article

iPSC-based drug discovery identified the Hippo signaling pathway as a therapeutic target in the fibrosis of NPHP1-deficient nephronophthisis

Eisei Sohara, Takayasu Mori, Takefumi Suzuki, Tamami Fujiki, Yutaro Mori, Yuta Nakano, Shintaro Mandai, Fumiaki Ando, Tomoki Yanagi, Hiroaki Kikuchi, Hiroaki Iwasa, Koichiro Susa, Yu Hara, Yutaka Hata, Shin‐ichi Uchida
article en
1 citations

Abstract

No abstract available for this paper.
Stem Cell Research & TherapyVol. 16(1)
Tokyo Medical and Dental University (JP), Abterra Biosciences (United States) (US), Shizuoka Medical Center (JP)
Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science
Openalex Percentile: Top 23%
Renal and related cancers
0.81
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

iPSC-based drug discovery identified the Hippo signaling pathway as a therapeutic target in the fibrosis of NPHP1-deficient nephronophthisis — Eisei Sohara, Takayasu Mori, et al. · Stem Cell Research & Therapy (2025) | TGRS Research Map | TGRS